Bioworld Financial Watch articles from November 2002

Bioworld Financial Watch archives from November 2002

New nucleoside analogue, drug combos promising in leukemia.
November 4, 2002... There's a simple way to describe leukemia--it's a blood cancer that starts in the bone marrow and is recognized by the proliferation of leukocytes, or white blood cells--but sifting through the subtypes, available treatments and would-be...

Money raised by biotech in 2002 Vs. 2001.
November 4, 2002... Money Raised By Biotech In 2002 Vs. 2001 Jan. 1 - Oct. 31, Jan. 1 - Nov. 1, 2002: $9,053.11M 2001: $10,053.45M Public/Other * 4,954 3,948 Private Biotechs ...

10 Biggest U.S. Gainers & Losers for the Week.
November 4, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) MacroChem 132.14 Genz Mol Oncol 119.44 Alliance 105.88 British Biotech 77.50 Targeted Genetics 75.44 Inspire Pharma 65.29 BioTransplant...

Biotechnology company deals with other biotechnology companies: collaborations, agreements, equity participation, Sept. 25--Oct. 30, 2002 #.
November 4, 2002... Biotechnology Company Deals With Other Biotechnology Companies: Collaborations, Agreements, Equity Participation, Sept. 25--Oct. 30, 2002 # Company * Company * (Country; (Country; Symbol) ...

Biotechnology company deals with miscellaneous companies: collaborations, agreements, equity participation, Sept. 25--Oct. 30, 2002 #.
November 4, 2002... Biotechnology Company Deals With Miscellaneous Companies: Collaborations, Agreements, Equity Participation, Sept. 25--Oct. 30, 2002 # Company * Company * Type/Product Area (Country; (Country) Symbol) ...

Manufacturing, marketing and distribution agreements between biotech companies: Sept. 25--Oct. 30, 2002 #.
November 4, 2002... Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Sept. 25 -- Oct. 30, 2002 # Company * Company * Product (Country; (Country Symbol) Symbol) Cancer Genetics...

Biotech--biotech collaborations: modified and terminated agreements, Sept. 25--Oct. 30, 2002 #.
November 4, 2002... Biotech--Biotech Collaborations: Modified And Terminated Agreements, Sept. 25--Oct. 30, 2002 # I. MODIFIED AGREEMENTS Company * Company * Change from original (Country; (Country; agreement Symbol) ...

BioWorld stock report for public biotechnology companies.
November 4, 2002... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change Vol 10/25 11/1 WK YTD (000) 3D Pharma DDDP 2.94 2.94 ...

Triangle's new NRTI advancing player in HIV treatment arena.
November 11, 2002... Editor Study, patience and a kind of indomitable hope: such are the qualities required of the biotechnology investor, and of researchers in the HIV field. The HIV scourge continues to quietly claim victims--50,000 new infections every...

10 biggest U.S. gainers for the week.
November 11, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Vion Pharma 141.38 ViroPharma 66.42 Cytogen 64.52 DOR BioPharma 64.00 Ribozyme 54.76 OraSure Tech 47.63 Cellegy Pharma 37.73...

10 biggest U.S. losers for the week.
November 11, 2002... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Pharsight -40.00 Targeted Genetics -31.00 AutoImmune -23.53 BioTransplant -21.31 Incara Pharma -20.00 EntreMed -18.93 NeoRx Corp. ...

Money raised by biotech in 2002 Vs. 2001.
November 11, 2002... Money Raised By Biotech In 2002 Vs. 2001 Jan. 1 - Nov. 7, Jan. 1 - Nov. 8, 2002: $9,133.26M 2001: $11,170.3M Public/Other 4,972 4,368 Private Biotechs 2,847 ...

Public financing of biotechnology: October 2002.
November 11, 2002... Public Financing Of Biotechnology: October 2002 I. COMMENCED TRADING IN OCTOBER Company Date Date Shares/ Price Shares Lead, Other (Symbol) Filed Comm. Units (M) Out Underwriters ...

Other financings of public biotechnology companies: October 2002.
November 11, 2002... Other Financings Of Public Biotechnology Companies: October 2002 Total: $2.5M Company Type Of Number Of Amount (Symbol) # Financing Shares, Units Raised Or...

Venture capital and corporate investments in biotechnology companies: October 2002.
November 11, 2002... Venture Capital And Corporate Investments In Biotechnology Companies: October 2002 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $153.19M Company Location Date Anacor Palo Alto,...

Toronto stock exchange.
November 11, 2002... TORONTO STOCK EXCHANGE Company Symbol 11/1 11/8 % WK % YTD Volume Adherex AHX 0.4 0.38 -5.00 -9.52 132 Angiotech Pharma ANP 57.4 57.45 0.09 -35.45 200 Anormed ...

BioWorld stock report for public biotechnology companies.
November 11, 2002... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change 11/1 11/8 WK YTD 3D Pharma DDDP 2.94 3 ...

London stock exchange.
November 11, 2002... LONDON STOCK EXCHANGE Company Symbol 11/1 11/8 % WK % YTD Volume Acambis ACM 249 247.5 -0.60 -29.39 2006 Antisoma ASM 11.75 12 2.13 -66.20 1082 British Biotech ...

Cash-positive companies have best chance of impressing VCs.
November 18, 2002... Walk into any funding firm and you will see mountains of papers summarizing this company's dream and that company's vision. It's no easy task for venture capitalists to weed through the bulk and find a gem. Often, they may even overlook a...

10 biggest U.S. gainers for the week.
November 18, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Biotime 100.00 OraPharma 60.99 Aphton 56.60 Variagenics 43.75 Ortec Int'l 41.67 Genaissance 40.00 DOV Pharma 35.91 Sangamo 33.33...

Money raised by biotech.
November 18, 2002... Money Raised By Biotech In 2002 Vs. 2001 Jan. 1 - Nov. 14, Jan. 1 - Nov. 15, 2002: $9,163.31M 2001: $11,445.2M Public/Other * 4,987 4,364 Private Biotechs 2,863 ...

Clinical trial update.
November 18, 2002... Clinical Trial Update: October 2002 Company * Product (Country; Symbol) AUTOIMMUNE Amgen Inc. Kineret (AMGN) FDA-approved) Cambridge ...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals.
November 18, 2002... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: October 2002 Company * Product Description (Country; Symbol) CANCER Oxxon PrimeBoost Vaccine involving...

FDA submissions, approvals and other actions.
November 18, 2002... FDA Submissions, Approvals And Other Actions: October 2002 Company * Product Description (Country; Symbol) AUTOIMMUNE Amgen Inc. Enbrel Etancercept; tumor (AMGN) (FDA-approved)...

BioWorld stock report for Public Biotechnology Companies.
November 18, 2002... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change 11/8 11/15 WK YTD 3D Pharma DDDP 3 2.91 ...

10 biggest U.S. losers for the week.
November 18, 2002... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Ribozyme -40.00 Adv Tissue Sci -38.16 Essential Thera -37.50 Ligand -30.27 British Biotech -29.58 Antex Biologics -29.03 Hyseq ...

London stock exchange.
November 18, 2002... LONDON STOCK EXCHANGE Company Symbol 11/8 11/15 %WK %YTD Volume Acambis ACM 247.5 249 0.61 -28.96 1922 Antisoma ASM 12 13 8.33 -63.38 3136 British Biotech...

Toronto stock exchange.
November 18, 2002... TORONTO STOCK EXCHANGE Company Symbol 11/8 11/15 %WK %YTD Volume Adherex AHX 0.38 0.42 10.53 0.00 75 Angiotech Pharma ANP 57.45 55.58 -3.26 -37.55 98 Anormed ...

E&Y: biotech reaches globally for financing and opportunity.
November 25, 2002... To survive in tough economic times, a biotech company often needs two things: cash and the ability to reach money and markets overseas. The industry is growing dramatically outside of the U.S., predominantly in Europe and Asia. And with the...

Money raised by biotech.
November 25, 2002... Money Raised By Biotech In 2002 Vs. 2001 Jan. 1 - Nov. 21, Jan. 1 - Nov. 20, 2002: $9,267.22M 2001: $11,493.95M Public/ Other * 5,054 4,370 Private Biotechs 2,899 ...

10 biggest U.S. gainers for the week.
November 25, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Antex Biologics 63.64 Alexion Pharma 58.25 Synaptic Pharma 52.14 Dyax 51.07 Lynx Therapeutics 50.75 NeoRx Corp. 48.30 Sangamo ...

Collaborations between biotechnology companies and universities/non-profit institutions.
November 25, 2002... Collaborations Between Biotechnology Companies And Universities/Non-Profit Institutions: Aug. 2 - Nov. 15, 2002 Company * University/ Type Of (Country; Symbol) Non-Profit @ Agreement AaiPharma...

BioWorld stock report for Public Biotechnology Companies.
November 25, 2002... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change 11/15 11/22 WK YTD 3D Pharma DDDP 2.91 3.08 5.84...

10 biggest U.S. losers for the week.
November 25, 2002... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Immune Resp -56.93 Targeted Genetics -29.39 Genaissance -27.38 Photogen -25.00 NeoTherapeutics -21.74 IntraBiotics -21.62 BioTransplant ...

London stock exchange.
November 25, 2002... LONDON STOCK EXCHANGE Company Symbol 11/15 11/22 %WK %YTD Volume Acambis ACM 249 260.5 4.62 -25.68 1738 Antisoma ASM 13 29.25 125.00 -17.61 51219 British Biotech BBG...

Toronto stock exchange.
November 25, 2002... TORONTO STOCK EXCHANGE Company Symbol 11/15 11/22 %WK %YTD Volume Adherex AHX 0.42 0.35 -16.67 -16.67 126 Angiotech Pharma ANP 55.58 58.89 5.96 -33.83 164 Anormed ...